Login
Login     |     Register     |     Recover Username/Password

General Investing

Picks in the Asian Market

July 27, 2009

This week, as part of our Investing Strategies Report, we spoke with analyst Sandy Mehta of Acumen Capital Managment. Acumen is a company that focuses specifically on investing in Asian companies. Here are some of the companies they’re looking at favorably now:

  • Varitronix (710 HK)- “This is a maker of electronic components. They have leading market share in most of their business. They have a 6.5% dividend yield. The stock price today is $2 in Hong Kong, and they have $1.30 in net cash, so more than 60% of the value is net cash. The p/e on the stock is 3 times earnings. If you net out the cash, the p/e for the stock is 1 times earnings. There are good growth characteristics for this business and it’s just an unbelievably undervalued situation.”
  • Golden Meditech (801 HK)-“It’s a Hong Kong listed Chinese healthcare company that we believe will grow 30% top line and bottom line going forward. It’s trading at 6 times earnings. We’ve owned this stock since 2004 when we launched our Fund. One major catalyst coming up is that Golden Meditech is planning to list one of their healthcare businesses, and we think that this will unlock value. They did a similar thing when they listed one of their subsidiaries on the New York Stock Exchange three years back, and that also was quite successful to unlock value. We think that there is a catalyst here in addition to a very undervalued situation.”
  • Ascendas India Trust (AIT SP)- “This is a Singapore listed company but it’s a play on Indian real estate. This company has a 12% dividend yield. They just increased their dividend in May. Unlike so many companies in the world that are cutting their dividends, this company is actually increasing them. The stock trades right now at $0.67 in Singapore. The book value per share is $0.90. Our analysis suggests this book value per share will increase to $1 to $1.20 over the next one year. Currently the stock is trading at a 20% discount to its book value and we estimate, according to our model, that one year forward, it’s going to be trading at a 40% discount.”

For the complete Investing Strategies Report, including a full interview with Mr. Mehta and a variety of other portfolio managers, click here.


TSWT - Subscribe now!

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Over 20,000 CEO, Equity Analyst and Money Manager Interviews

TWST Newsletter

Weekly email with New In-Depth Interviews

Most Popular Interviews
Opportunities in Hepatitis C and Genomic Technologies
David Ferreiro

Published April 26, 2014 in Biotechnology and Pharmaceuticals

Buy ($75)
Investing in Health Care Innovation
Finny Kuruvilla

"We’re a faith-based and socially responsible investing firm"

Published May 16, 2013 in Investing in Health Care

Buy ($75)
A Health Sciences Fund with a Long-Term Focus
Mark W. Oelschlager

"The fund is about $40 million in assets"

Published May 16, 2013 in Investing in Health Care

Buy ($75)
High-Yield Canadian Power Companies
John McIlveen

Published May 14, 2013 in High-Yield Equity Securities

Buy ($75)
Most Popular Reports
Investing in Health Care

Published May 16, 2013

Topics Covered: Health Care - Electronic Health Record Adoption - Biotechnology and Pharmaceutical Investing - Biotechnology and Pharmaceuticals - Biotechnology and Pharmaceutical Companies Valuation - Platform Interoperability and Data Analytics - HITECH Act Incentives - Affordable Care Act
Buy ($175)
Internet Services

Published May 10, 2013

Topics Covered: Increased Mobile Content Traffic - Chinese Online Monetization Trends - Internet Infrastructure and Services Consolidation - Social Networking Economics -
Buy ($175)
Investing Strategies

Published May 10, 2013

Topics Covered: Investing in Financial Services - Long-Term Investing - Large Cap Investing - Value Investing - High Quality Companies - Bottom-up Investing - All-Cap Growth Investing - Investing in Emerging Markets
Buy ($175)
Top Company Interviews
TWST
Register for a Free Account to gain greater access to The Wall Street Transcript right now